Safety, Tolerability, and Pharmacokinetics of Anaprazole, a Novel Proton Pump Inhibitor, in Healthy Chinese Subjects

Anaprazole, a newly developed oral proton pump inhibitor, was evaluated for safety, tolerability, and pharmacokinetics in healthy Chinese subjects. This study involved administering either anaprazole sodium enteric‐coated tablet or placebo, followed by monitoring the incidence and severity of any ad...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology in drug development 2024-07, Vol.13 (7), p.782-789
Main Authors: Wang, Fangfang, Niu, Xiaoye, Liu, Fei, Ma, Xifeng, Cheng, Fang, Xu, Haiyan, Wang, Li, Xu, Yanjun, Li, Haiyan
Format: Article
Language:English
Subjects:
anaprazole sodium
Oral administration
Pharmacokinetics
phase I clinical trial
proton pump inhibitor
safety
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!